Coronary microvascular remodeling and ischaemia in hypertension;Remodelage microvasculaire et ischémie coronaire dans l'hypertension artérielle

American Journal of Cardiovascular Drugs

Volumn 4, Issue SPEC. ISS. 1, 2004, Pages 25-30

  Camici, Paolo G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; INDAPAMIDE; PERINDOPRIL;

ANGIOCARDIOGRAPHY; ARTERIOLE; COMORBIDITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DEATH; DETERIORATION; DISEASE SEVERITY; DOSE RESPONSE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MICROCIRCULATION; MICROVASCULATURE; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; REST; REVIEW; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 4544295792     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200404991-00008     Document Type: Review

References (29)

1. Ringvist I, Fisher LD, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983; 71: 1854-66
2. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. New Engl J Med 1994; 330: 1782-8
3. Maseri A. Coronary vasoconstriction: visible and invisible. N Engl J Med 1991; 325: 1579-80
4. Maseri A, Crea F, Cianflone D. Myocardial ischemia caused by distal coronary vasoconstriction. Am J Cardiol 1992; 70: 1602-5
5. Pupita G, Maseri A, Kaski JC, et al. Myocardial ischemia caused by distal coronary constriction in stable angina pectoris. N Engl J Med 1990; 323: 514-20
6. Chilian WM, Eastham CL, Layne SM, et al. Small vessel phenomena in the coronary microcirculation: Phasic intramyocardial perfusion and microvascular dynamics. Prog Cardiovasc Dis 1988; 31: 17-38
7. Marcus ML, Chilian WM, Kanatsuka H, et al. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990; 82: 1-7
8. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986; 251: H779-88
9. Chilian WM, Layne SM, Eastham CL, et al. Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction. Circ Res 1989; 64: 376-88
10. Toyota E, Koshida R, Hattan N, et al. Regulation of the coronary vasomotor tone: What we know and where we need to go. J Nucl Cardiol 2001; 8: 599-605
11. L'Abbate A, Marzilli M, Ballestra AM, et al. Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog's heart. Cardiovasc Res 1980; 14: 21-9
12. Sambuceti G, Marzilli M, Fedele S, et al. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Circulation 2001; 103: 2352-60
13. De Silva R, Camici PG. The role of positron emission tomography in the investigation of coronary circulatory function in man. Cardiovasc Res 1994; 28: 1595-612
14. Camici PG. Positron emission tomography and myocardial imaging. Heart 2000; 83: 475-80
15. Dutka DP, Camici PG. The contribution of positron emission tomography to the study of ischemic heart failure. Prog Cardiovasc Dis 2001; 43: 399-418
16. Camici PG, Rimoldi OE. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003; 57: 302-11
17. 15O and 3-dimentional PET: an experimental validation. J Nucl Med 2002; 43: 1031-40
18. 15O∧belled water and PET. J Nucl Med 1999; 40: 1848-56
19. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000; 102: 1233-8
20. Brush JE, Cannon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-7
21. Schwartzkopff B, Motz W, Frenzel H, et al. Hypertension: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003
22. Galderisi M, de Simone G, Cicala S, et al. Coronary flow reserve in hypertensive patients with appropriate and inappropriate left ventricular mass. J Hypertens 2003; 21: 2183-8
23. Kozàkovà M, de Simone G, Morizzo C, et al. Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension 2003; 41: 224-9
24. Treasure CB, Klein JL, Vita JA, et al. Coronary circulation: Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93
25. Chilian WM, Koshida R. EDHF and NO: Different pathways for production - similar actions. Circ Res 2001; 89: 648-9
26. Matsunaga T, Warltier DC, Weilhrauch DW, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098-103
27. Choudhury L, Rosen SD, Patel D, et al. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy: a study with positron emission tomography. For Heart J 1998; 18: 108-16
28. Cecchi, F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349: 1027-35
29. Mourad J-J, Hanon O, Deverre R-J, et al. Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study. J Renin Angiotensin Aldosterone Syst 2003; 4: 94-5